"Cell Cycle Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS.
| Descriptor ID |
D018797
|
| MeSH Number(s) |
D12.776.167
|
| Concept/Terms |
Cell Cycle Proteins- Cell Cycle Proteins
- Cell Division Cycle Proteins
- Cell-Cycle Regulatory Proteins
- Cell Cycle Regulatory Proteins
- cdc Proteins
|
Below are MeSH descriptors whose meaning is more general than "Cell Cycle Proteins".
Below are MeSH descriptors whose meaning is more specific than "Cell Cycle Proteins".
This graph shows the total number of publications written about "Cell Cycle Proteins" by people in this website by year, and whether "Cell Cycle Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 4 | 0 | 4 |
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 1 | 2 |
| 2000 | 5 | 2 | 7 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 4 | 1 | 5 |
| 2004 | 2 | 2 | 4 |
| 2005 | 10 | 4 | 14 |
| 2006 | 3 | 0 | 3 |
| 2007 | 5 | 1 | 6 |
| 2008 | 1 | 4 | 5 |
| 2009 | 1 | 6 | 7 |
| 2010 | 5 | 2 | 7 |
| 2011 | 4 | 3 | 7 |
| 2012 | 5 | 3 | 8 |
| 2013 | 4 | 0 | 4 |
| 2014 | 4 | 3 | 7 |
| 2015 | 7 | 7 | 14 |
| 2016 | 1 | 3 | 4 |
| 2017 | 4 | 2 | 6 |
| 2018 | 4 | 1 | 5 |
| 2019 | 3 | 2 | 5 |
| 2020 | 3 | 2 | 5 |
| 2021 | 5 | 3 | 8 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Cycle Proteins" by people in Profiles.
-
The cohesin modifier ESCO2 is stable during DNA replication. Chromosome Res. 2023 01 28; 31(1):6.
-
A Novel Translational Activation of HIF1a Promotes Pancreatic Cancer Growth Through Glycolytic Reprogramming. Gastroenterology. 2022 04; 162(4):1040-1042.
-
The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis. Mol Cancer. 2021 11 10; 20(1):145.
-
Ycs4 Subunit of Saccharomyces cerevisiae Condensin Binds DNA and Modulates the Enzyme Turnover. Biochemistry. 2021 11 16; 60(45):3385-3397.
-
The CRL4DTL E3 ligase induces degradation of the DNA replication initiation factor TICRR/TRESLIN specifically during S phase. Nucleic Acids Res. 2021 10 11; 49(18):10507-10523.
-
Frequent expression of a novel cancer testis antigen, protein kinase human monopolar spindle 1 (hMps1/TTK) in human urinary bladder transitional cell carcinoma. Drug Discov Ther. 2021 Sep 22; 15(4):204-209.
-
Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers. Int J Radiat Oncol Biol Phys. 2021 12 01; 111(5):e54-e62.
-
Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Mol Cell. 2021 08 19; 81(16):3368-3385.e9.
-
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors. Clin Cancer Res. 2021 07 15; 27(14):3834-3844.
-
Physical confinement during cancer cell migration triggers therapeutic resistance and cancer stem cell-like behavior. Cancer Lett. 2021 05 28; 506:142-151.